首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Evaluation of a series of 137 carcinomas of the endometrium of stage I TNM/UICC
【24h】

Evaluation of a series of 137 carcinomas of the endometrium of stage I TNM/UICC

机译:I期TNM / UICC子宫内膜癌系列137例的评估

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To assess retrospectively the long-term results of the combination of surgery and radiotherapy in carcinoma classified cT1. PATIENTS AND METHODS: From 1974 to 1993, 137 women suffering from endometrial carcinoma cT1Nx-0 M0 were entered into the study. The median age was 62 years (range: 39-85 years) and the median follow up was 67 months (range: 0-224 months). RESULTS: Surgery was performal in 132 women (96.35%). For cT1, the 5-year overall and specific survivals were 81.1% and 84.5%, respectively. The 10-year overall and specific survivals were 68.8% and 82.2%, respectively. Concerning cT1pT1, the 5-year overall and specific survivals, were 83.9% and 87.4%. The 10-year overall and specific survivals were 71.1% and 85%, respectively. Histological grade, pelvic lymph node involvement and myometrial infiltration influence significantly the overall and specific survivals of cT1pT1 tumors. According to multivariate analysis, pelvic lymph node involvement was a powerful prognostic factor for both the overall and specific survivals. If we rule out pelvic lymph node involvement, WHO histological grade was a significant prognostic factor. CONCLUSION: Combination of surgery and radiotherapy is still a common procedure for cT1 tumors. When surgery is done before radiotherapy, tailored irradiation may further take place, according to WHO histological grade and pelvic lymph node status.
机译:目的:回顾性评估手术和放疗联合治疗分类为cT1的癌症的长期结果。患者与方法:从1974年至1993年,共有137名患有子宫内膜癌cT1Nx-0 M0的妇女进入研究。中位年龄为62岁(范围:39-85岁),中位随访时间为67个月(范围:0-224个月)。结果:132例妇女(96.35%)的外科手术表现良好。对于cT1,5年总生存率和特定生存率分别为81.1%和84.5%。 10年总生存率和特定生存率分别为68.8%和82.2%。关于cT1pT1,5年总生存率和特定生存率分别为83.9%和87.4%。 10年总生存率和特定生存率分别为71.1%和85%。组织学分级,骨盆淋巴结受累和肌层浸润显着影响cT1pT1肿瘤的总体生存和特异性生存。根据多因素分析,骨盆淋巴结受累是整体生存和特定生存的重要预后因素。如果我们排除盆腔淋巴结受累,WHO的组织学分级是重要的预后因素。结论:手术和放疗相结合仍然是治疗cT1肿瘤的常见方法。如果在放疗前进行手术,则根据WHO的组织学等级和盆腔淋巴结状态,可能会进一步进行特定的照射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号